PCVX
NASDAQ · Biotechnology
Vaxcyte Inc
$63.89
+1.97 (+3.18%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+5.0% upside
Low Target
$56.09
Average Target
$67.08
High Target
$108.72
Current Price
$63.89
Current
$63.89
$63.89
Target
$67.08
$67.08
$56.09
$67.08 avg
$108.72
Scenario Analysis
Bear Case
$56.09
-12.2%
Low target
Base Case
$67.08
+5.0%
Avg target
Bull Case
$108.72
+70.2%
High target
Risk/Reward
5.7x
Highly favorable
Price in Context
52-Week High
$90.75
-29.6% from high
52-Week Low
$39.87
+60.2% from low
50-Day SMA
$61.71
+3.5% vs SMA
200-Day SMA
$57.37
+11.4% vs SMA
RSI (14)
50.4
Neutral
Target vs 52W High
$67.08
-26.1% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $-2.17
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |